Overview
Selank is a synthetic peptide analogue of tuftsin, an endogenous immunomodulatory tetrapeptide. Extending the tuftsin sequence improves its metabolic stability, and Selank has become a widely referenced research compound for exploring anxiolytic pathways without the sedative or dependence liabilities associated with conventional benzodiazepine-class research comparators.
Selank 10mg is planned for the Indonesia catalogue. Register your interest and we will notify you when it becomes available.
Key Research Areas
Anxiolytic Pathway Research
Selank is studied for its anxiolytic-like effects in animal models, investigated as a research alternative that avoids sedation and motor-impairment endpoints.
GABA & Serotonin Modulation
Investigated for its modulatory effects on GABAergic and serotonergic signalling systems relevant to mood and stress-response research.
Neuroimmune Signalling
As a tuftsin analogue, Selank is studied for immunomodulatory activity and crosstalk between neural and immune signalling pathways.
BDNF Expression Research
Explored alongside related neuropeptides for its potential influence on brain-derived neurotrophic factor (BDNF) expression models.
Product Specifications
| Format | Lyophilised powder |
| Quantity | 10mg per vial |
| Purity | >98% (HPLC verified) |
| Storage | Refrigerate at 2–8°C. Stable 24 months lyophilised. |
| Availability | Launching Soon |
| Research use | In vitro / laboratory use only |